International conferences and seminars

10th Anti-Infectives Partnering & Deal-Making

GTC's 10th Anti-infectives Partnering and Deal-Making Conference, taking place on July 8-10, 2013 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a collegial setting. Previous GTC conferences have been catalytic to several successful partnerships and in 2013 we expect this trend to continue.

GTC's Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

Sessions of the conference include:
Multi Drug Resistant Gram Negative Infections
C-Difficile Infections
Regulatory Guidance and Overcoming Challenges in Anti-infectives Development
Recent Advances in Anti-Infectives
Neglected Infectious Diseases
Old Drugs, New Drugs
Novel Diagnostics Against Drug Resistance
Government Collaborations and Non-dilutive Funding

There will also be several interactive Panel Discussions on:
Current Trends and Future in Anti-infectives Development
Licensing vs Co-development Partnerships
Investment Opportunities with Venture Capitalists
Finding the Middle Ground in Partnerships with Big Pharma and Govt.

Register 3 for the price of 2 with the coupon code rcdvb!

We look forward to seeing you at the conference!

Best regards,
2013 Anti-Infectives Conference Advisory Committee